Yair Lotan

44PUBLICATIONS
206CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Clinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|Jul 28, 2026
Unveiling the Paradoxical Tumor-Suppressive Role of CCL2/CCR2 in Bladder Cancer: A Novel Immunotherapeutic Strategy.

|Jul 02, 2026
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

|Apr 01, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Roberto Contieri, Paolo Gontero, Rodolfo Hurle

|Mar 27, 2026
Novel Immune Checkpoint Inhibitor and Antibody-Drug Conjugate Approaches in the Perioperative Management of Muscle-Invasive Bladder Cancer.

Joseph Vento, Tian Zhang, Yair Lotan

|Jul 15, 2025
Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy.

Joep J de Jong, Moritz J Reike, Yair Lotan

Pageof 8

Frequent Collaborators

7 joint publications

Roger Li

5 joint publications

Laura S Mertens

4 joint publications

Andrea Mari

4 joint publications

Siamak Daneshmand